Intrexon reported $14.92M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Agenus AGEN:US $ 25.4M 6.02M
Amgen AMGN:US $ 4677M 451M
Anika Therapeutics ANIK:US $ 21.8M 3.67M
AstraZeneca AZN:LN 9.11B 169M
Bristol Myers Squibb BMY:US $ 9177M 452M
ChemoCentryx CCXI:US 5.25M 3.24M
Gilead Sciences GILD:US $ 5166M 549M
GlaxoSmithKline GSK:LN 6.14B 283M
Heron Therapeutics HRTX:US $ 12.1M 2.39M
Intrexon XON:US $ 14.92M 5.63M
Karyopharm Therapeutics KPTI:US $ 46.24M 79.28M
Ligand Pharmaceuticals LGND:US $ 40.99M 19.5M
MacroGenics MGNX:US 11.05M 2.15M
Mannkind MNKD:US $ 0.99M 0.09M
Merk MRK:US $ 10567M 873M
Novartis NOVN:VX 9.06B 463M
Peregrine Pharmaceuticals PPHM:US $ 9.09M 0.1M
Rigel Pharmaceuticals RIGL:US $ 16.61M 3.31M
Thermo Fisher Scientific TMO:US $ 5464M 210M
Veracyte VCYT:US $ 44.07M 0.38M
YTE INCY:US $ 696.02M 128.26M